Simplex Trading, LLC Sigilon Therapeutics, Inc. Transaction History

Simplex Trading, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 02, 2023	SELL	$0.29 - $0.69 $6 - $14	-21 Reduced 1.13%	1,831 $0
Q3 2022 Nov 04, 2022	SELL	$0.48 - $0.86 $0 - $0	-1 Reduced 0.05%	1,852 $0
Q1 2022 May 02, 2022	BUY	$1.24 - $3.03 $1,610 - $3,935	1,299 Added 234.48%	1,853 $2,000
Q4 2021 Feb 23, 2022	BUY	$2.58 - $6.13 $1,429 - $3,396	554 New	554 $1,000

Ticker SGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,399,300
Description
Sigilon Therapeutics, Inc., a clinical stage biotechnology company, develops functional cures for patients with chronic diseases. Its lead product candidate is SIG-001, which is in Phase I/II clinical trial to prevent bleeding episodes in patients with moderate to severe Hemophilia A. The company is also developing SIG-005 to treat the non-neuro...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.